White House withdraws Heidi Overton FDA nomination amid Senate opposition
The White House withdrew President Donald Trump's nomination of Heidi Overton to lead the Food and Drug Administration on Tuesday ahead of a scheduled Senate committee vote.

Withdrawal confirmed by officials
A White House official told The Guardian that the administration dropped the nomination. Sources speaking to Reuters confirmed this move occurred one day before the pivotal Senate health committee vote. Republicans hold only a one-vote majority on the panel, meaning losing a single member would have blocked confirmation. Overton was set to face scrutiny regarding her willingness to break from President Trump's agenda.
Context of the nomination
President Trump nominated Overton in August following the resignation of former commissioner Marty Makary. The agency had lost more than 4,500 staff members over the past year under the previous administration. Overton previously worked for conservative groups aligned with the president's agenda and opposed childhood vaccines. Senator Bill Cassidy criticized her support for breaking up combination vaccines as almost disqualifying.
Reactions and future plans
Mini Timmaraju of Reproductive Freedom for All stated Overton posed a serious threat to medication abortion access. The group celebrated the decision as a victory against an anti-abortion agenda. The White House is now weighing Senator Roger Marshall of Kansas as a potential replacement nominee. Republicans are racing to confirm current nominees before handing power to Democrats in January.
All 3 outlets report consistently
No differences in figures, names or dates across these reports.
- The Hill
- The Guardian
- Business Recorder
Reported by
3 independent outlets. Headlines as published. Links open the original report.